• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症血浆和正常血浆中水杨酸盐的蛋白质结合情况。

Protein binding of salicylate in uremic and normal plasma.

作者信息

Borgå O, Cederlöf I O, Ringberger V A, Norlin A

出版信息

Clin Pharmacol Ther. 1976 Oct;20(4):464-75. doi: 10.1002/cpt1976204464.

DOI:10.1002/cpt1976204464
PMID:975718
Abstract

Protein binding of salicylate was studied by equilibrium dialysis at 37 degrees C in plasma from uremic patients and healthy subjects. The protein binding was considerably lower in the uremic plasma at all salicylate concentrations studied (14 to 1,400 mug/ml). Scatchard plots of the data were computer-analyzed assuming binding to the classes of binding sites. According to this analysis, the binding to the class of primary binding sites was considerably decreased in the uremic plasma. In addition to the effect of the uremic state, the binding was considerably decreased at high therapeutic plasma levels and at low albumin levels. The combined effect of two or three of these factors may lead to unexpectedly high unbound fractions of salicylate, which should be considered in the monitoring of plasma salicylate levels in patients.

摘要

在37摄氏度下,采用平衡透析法研究了尿毒症患者和健康受试者血浆中水杨酸盐的蛋白结合情况。在所研究的所有水杨酸盐浓度(14至1400微克/毫升)下,尿毒症血浆中的蛋白结合率均显著降低。假设与不同类别的结合位点结合,对数据进行Scatchard作图并通过计算机分析。根据该分析,尿毒症血浆中与主要结合位点类别的结合显著减少。除了尿毒症状态的影响外,在高治疗血浆水平和低白蛋白水平下,结合也显著降低。这些因素中的两个或三个因素共同作用可能导致水杨酸盐的游离分数意外升高,这在监测患者血浆水杨酸盐水平时应予以考虑。

相似文献

1
Protein binding of salicylate in uremic and normal plasma.尿毒症血浆和正常血浆中水杨酸盐的蛋白质结合情况。
Clin Pharmacol Ther. 1976 Oct;20(4):464-75. doi: 10.1002/cpt1976204464.
2
Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.慢性肾衰竭和血液透析对双氟尼酸血浆蛋白结合的影响。
Clin Pharmacol Ther. 1980 May;27(5):628-35. doi: 10.1038/clpt.1980.89.
3
Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.尿毒症患者苯妥英钠的血浆蛋白结合受损及水杨酸的置换作用。
Clin Pharmacol Ther. 1976 Jul;20(1):36-47. doi: 10.1002/cpt197620136.
4
Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.类风湿性关节炎患者中水杨酸盐与滑液和血浆蛋白结合的特征分析。
Eur J Clin Pharmacol. 1980 Nov;18(5):403-6. doi: 10.1007/BF00636793.
5
Plasma protein carbamylation and decreased acidic drug protein binding in uremia.尿毒症时血浆蛋白氨甲酰化及酸性药物蛋白结合率降低
Clin Pharmacol Ther. 1980 May;27(5):612-8. doi: 10.1038/clpt.1980.87.
6
Inhibition of salicylate binding to normal plasma by extracts of uremic fluids.尿毒症患者体液提取物对水杨酸盐与正常血浆结合的抑制作用。
Am J Kidney Dis. 1984 Sep;4(2):153-61. doi: 10.1016/s0272-6386(84)80064-5.
7
Salicylate clearance, the resultant of protein binding and metabolism.水杨酸盐清除率,是蛋白质结合和代谢的结果。
Clin Pharmacol Ther. 1979 Sep;26(3):380-9. doi: 10.1002/cpt1979263380.
8
Protein binding of salicylate in cutaneous hepatic porphyria.皮肤性肝卟啉症中水杨酸盐的蛋白质结合
Eur J Clin Pharmacol. 1978 Jun 19;13(4):309-13. doi: 10.1007/BF00716368.
9
Correction of protein binding defect in uremic sera by charcoal treatment.通过活性炭处理纠正尿毒症血清中的蛋白质结合缺陷。
J Lab Clin Med. 1976 Apr;87(4):637-47.
10
Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration.
Eur J Clin Pharmacol. 1985;28(3):339-45. doi: 10.1007/BF00543334.

引用本文的文献

1
Monitoring plasma concentrations of salicylate.监测水杨酸盐的血浆浓度。
Clin Pharmacokinet. 1980 Sep-Oct;5(5):424-40. doi: 10.2165/00003088-198005050-00002.
2
Binding of tienilic acid (Diflurex) to human serum albumin and to plasma of normal subjects and uraemic patients.替尼酸(双氟雷克斯)与正常人及尿毒症患者的人血清白蛋白和血浆的结合。
Eur J Drug Metab Pharmacokinet. 1980;5(2):99-106. doi: 10.1007/BF03189452.
3
High unbound fraction of salicylate in plasma during intoxication.中毒期间血浆中水杨酸的游离分数高。
Br J Clin Pharmacol. 1981 Jun;11(6):625-6. doi: 10.1111/j.1365-2125.1981.tb01182.x.
4
Pharmacokinetics of drug overdose.药物过量的药代动力学。
Clin Pharmacokinet. 1981 May-Jun;6(3):161-92. doi: 10.2165/00003088-198106030-00001.
5
Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.类风湿关节炎中水杨酸盐体外血清蛋白结合率的降低。
Eur J Drug Metab Pharmacokinet. 1984 Apr-Jun;9(2):109-16. doi: 10.1007/BF03189613.
6
Alteration of drug-protein binding in renal disease.肾脏疾病中药物与蛋白质结合的改变。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:18-26. doi: 10.2165/00003088-198400091-00003.
7
Endogenous ligand(s) decrease drug--protein binding in uremic sera: a fluorescence probe study.
Klin Wochenschr. 1983 Jul 1;61(13):649-53. doi: 10.1007/BF01487581.
8
Protein binding of enprofylline.
Eur J Clin Pharmacol. 1983;25(5):703-8. doi: 10.1007/BF00542362.
9
Plasma protein binding of dipyrone metabolites in man.人身上安乃近代谢物的血浆蛋白结合情况。
Eur J Clin Pharmacol. 1985;29(1):67-71. doi: 10.1007/BF00547371.
10
Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration.
Eur J Clin Pharmacol. 1985;28(3):339-45. doi: 10.1007/BF00543334.